The accumulation of advanced glycation end products (AGEs) in diabetic patients induces vascular endothelial injury. Promyelocytic leukemia zinc finger protein (PLZF) is a transcription factor that can be activated by low-temperature far-infrared (FIR) irradiation to exert beneficial effects on the vascular endothelium. In the present study, we investigated the influence of FIR-induced PLZF activation on AGE-induced endothelial injury both in vitro and in vivo. FIR irradiation inhibited AGEinduced apoptosis in human umbilical vein endothelial cells (HUVECs). PLZF activation increased the expression of phosphatidylinositol-3 kinases (PI3K), which are important kinases in the autophagic signaling pathway. FIR-induced PLZF activation led to autophagy in HUVEC, which was mediated through the upregulation of PI3K. Immunofluorescence staining showed that AGEs were engulfed by HUVECs and localized to lysosomes. FIR-induced autophagy promoted AGEs degradation in HUVECs. In nicotinamide/streptozotocin-induced diabetic mice, FIR therapy reduced serum AGEs and AGEs deposition at the vascular endothelium. FIR therapy also reduced diabetes-induced inflammatory markers in the vascular endothelium and improved vascular endothelial function. These protective effects of FIR therapy were not found in PLZF-knockout mice. Our data suggest that FIR-induced PLZF activation in vascular endothelial cells protects the vascular endothelium in diabetic mice from AGEinduced injury.
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Many studies have revealed that advanced glycation end products (AGEs) play a critical role in promoting diabetic vascular dysfunction and diabetes development 5 . Reducing sugars can modify proteins by Maillard reaction, which extremely accelerates under diabetes to form AGEs 6 . Recent findings suggest that N-ε -carboxymethyl-lysine (CML), a major AGE in vivo, is the key modulators for the development of nonproliferative retinopathy among type 2 diabetic patients 7 . Interaction between AGEs and their receptor (RAGE) increases both mitochondrial and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species (ROS) generation 8 . Excessive ROS is cytotoxic and contributes to vascular inflammation, thrombosis and diabetic vascular complications 8, 9 . Both RAGE-mediated ROS generation and high glucose promote apoptosis in endothelial cells by activating nuclear factor-kappa B (NF-κ B), c-Jun NH2-terminal kinase and caspases 3, 10 . NF-κ B is a key molecule in regulating expression changes of inflammatory mediators such as inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1, and major histocompatibility complex class II 11 . Additionally, the activation of RAGE induce various pro-inflammatory mediators in endothelia cells, such as transforming growth factor beta 1 (TGF-β 1), intercellular adhesion molecule-1 and monocyte chemotactic protein-1 (MCP-1) 12, 13 . The pro-inflammatory mediators induce adhesion of monocyte/macrophage and lymphocytes to endothelial cells, which is also an early and central event in diabetic vascular dysfunction development 5 . Based on the studies described above, endothelial apoptosis and inflammation are major AGE-induced injury in diabetic vascular endothelium.
Promyelocytic leukaemia zinc finger protein (PLZF) is a nuclear transcription factor belonging to the BTB/ POZ family 14 . It is recognized as an inducer of innate-like features in many different lymphocytes 15 . PLZF has also been directly linked to tumor suppression via its transcriptional repression of the c-myc oncogene 16 . Many cell types express PLZF to mediate various signaling, growth regulatory and diverse functions, such as homeostasis, neoplasia, and apoptosis 17, 18 . Our recent study shows that low-temperature far-infrared (FIR) induces PLZF nuclear translocation to increase PI3K expression in human umbilical vein endothelial cells (HUVECs) 19 . The PI3K family (classes I and III) has been shown to stimulate autophagy 20 . Therefore, FIR-induced PLZF nuclear translocation has potential to induce autophagy in vascular endothelial cells.
Autophagy is a process involving degradation of long-lived proteins, which consists of the formation of autophagosomes, the fusion of autophagosomes and lysosomes, the degradation of autophagic cargo by the lysosomal hydrolases, and the recycling of the products 21, 22 . Two proteins, beclin-1 and microtubule-associated protein 1 light chain 3 (LC3), play important roles in the process of autophagy. Beclin-1 is an integral protein in the class III PI3K pathway and triggers autophagy 23 . The cytoplasmic form of LC3 (LC3-I) becomes membrane-associated (LC3-II) to form autophagosome during autophagy 24 . Many studies show a protective role of autophagy in AGE-induced injury in HUVECs 25, 26 . Considering the possibility of PLZF-mediated autophagy, FIR-induced PLZF nuclear translocation may protect vascular endothelial cells from AGE-induced injury. This study tested the hypothesis in vitro and in vivo, and revealed its autophagy-associated mechanism.
Results

FIR irradiation protects HUVECs from AGE-induced apoptosis.
The treatment of 250 μ g/ml AGEbovine serum albumin (BSA) considerably induced apoptosis in HUVECs in 48 h as revealed by annexin V/PI double staining and flow cytometry ( Fig. 1a and b) . FIR irradiation dose-dependently reduced AGE-BSA-induced apoptosis. Western blot analysis revealed that AGE-BSA reduced Bcl-2 and Bcl-xL expression and increased cleaved caspases-3 in HUVECs (Fig. 1c) . FIR irradiation considerably increased Bcl-2 and Bcl-xL expression, and decreased cleaved caspases-3 in AGE-BSA-treated cells. The cell viability assay revealed that AGE-BSA significantly reduced HUVEC viability, and FIR irradiation blocked the influence of AGE-BSA and mildly increased HUVEC viability (Fig. 1d ).
PLZF nuclear translocation is necessary for the anti-apoptotic effect of FIR. To confirm the influence of FIR irradiation on PLZF activation, we monitored the distribution of PLZF in HUVECs by immunofluorescence staining. As shown in Fig. 2a , FIR irradiation induced the translocation of PLZF to nuclei in HUVECs. Western blots revealed that FIR irradiation induced PI3K p85 and PI3K III expression, which was not influenced by AGE-BSA treatment (Fig. 2b) . The expression of phospho-Akt was also increased by FIR irradiation, which indicated that total activity of PI3K increased in FIR-treated cells. Neither FIR nor AGE-BSA influenced the expression of RAGE. We used PLZF siRNA transfection to block PLZF expression in HUVECs, and then found that FIR irradiation failed to elevate the expression of PI3K p85, PI3K III, and phospho-Akt (Fig. 2b) . PLZF siRNA transfection blocked the inhibitory effect of FIR on AGE-BSA-induced apoptosis in HUVECs (Fig. 2c) . Two inhibitors of PI3Ks, 3-methyladenine (3-MA) and wortmannin, also inhibited the anti-apoptotic effect of FIR in AGE-BSA-treated HUVECs (Fig. 2d) . These results reveal that FIR-induced PLZF nuclear translocation upregulates PI3Ks to inhibit AGE-BSA-induced apoptosis in HUVECs.
FIR-induced PLZF activation induces autophagy in HUVECs.
Because PI3K classes I and III were involved in autophagy, we further evaluated the connection between FIR and autophagy using Cyto-ID Green that selectively labels autophagic vacuoles. As shown in Fig. 3a , FIR irradiation induced obvious autophagic vacuole accumulation in HUVECs. Autophagic vacuole accumulation appeared weak in the cells with AGE-BSA treatment alone. Both 3-methyladenine (3-MA) and wortmannin completely inhibited FIR-induced autophagic vacuole accumulation autophagic vacuole accumulation. Western blots revealed that FIR irradiation increased beclin-1 and LC3-II expression in HUVECs, which was blocked by PLZF siRNA transfection (Fig. 3b) . AGE-BSA also increased beclin-1 and LC3-II expression in HUVECs but the effect was weaker than that of FIR irradiation. We used beclin-1 siRNA transfection to block beclin-1 expression in HUVECs, and then found that FIR irradiation failed to elevate LC3-II expression (Fig. 3c) . FIR-induced autophagic signals were also confirmed in vivo. Vascular endothelium in the ears of FIR-irradiated mice expressed higher levels of beclin-1 and LC3 compared with that in control mice (Fig. 3d) . Beclin-1 siRNA transfection also blocked the inhibitory effect of FIR on AGE-BSA-induced apoptosis in HUVECs (Fig. 3e) . These results suggest that FIR-induced PLZF activation induces autophagy in vascular endothelial cells, which plays a critical role in the anti-apoptotic effect of FIR.
PLZF-mediated autophagy promotes AGEs degradation in HUVECs.
Lysosomes are involved in the degradation of autophagic cargo. To evaluate the influence of PLZF-mediated autophagy on lysosome formation, we monitored the expression of the Lysosomal-associated membrane protein 1 (LAMP-1) in HUVECs. As shown in Fig. 4a , FIR irradiation considerably increased LAMP-1 expression, whether HUVECs were treated with AGE-BSA or not. Beclin-1 siRNA transfection blocked FIR-induced LAMP-1 increase. Immuno-fluorescence staining also showed that FIR irradiation increased LAMP-1 expression and scatter in HUVECs but not in beclin-1 siRNA-transfected cells (Fig. 4b) . With AGE-BSA treatment, we found co-localization of LAMP-1 and CML in the HUVECs with AGE-BSA treatment alone, but not in the cells with AGE-BSA and FIR treatments (Fig. 4c) . Both FIR-induced LAMP-1 and co-localization of LAMP-1 and CML were inhibited by bafilomycin A1, an inhibitor for acidification and protein degradation in lysosomes (Fig. 4c) . This result suggests that AGEs can be engulfed and accumulate in HUVECs, which is prevented by FIR irradiation. In Western blotting assays, we found that AGE-BSA treatment increased intracellular CML in HUVECs (Fig. 4d) . FIR irradiation considerably decreased intracellular CML in AGE-BSA-treated cells. But this phenomenon was not found in beclin-1 siRNA-transfected cells. FIR didn't influence the intracellular CML level in bafilomycin A1-treated HUVECs at all (Fig. 4d) , indicating that the involvement of lysosomes is necessary for FIR-reduced intracellular AGEs. This result also revealed that FIR didn't influence the engulfment of AGEs in AGE-BSA-treated cells. In quantitative analyses, FIR irradiation didn't influence the quantity of AGE-BSA in culture medium without cells (Fig. 4e) . With the existence of HUVECs, however, FIR irradiation decreased AGE-BSA in culture medium, which was blocked by beclin-1 siRNA transfection and bafilomycin A1. These results suggest that PLZF-mediated autophagy promotes AGEs degradation in HUVECs to reduce extracellular AGEs.
FIR therapy reduces serum AGEs in diabetic mice.
To further evaluate PLZF-mediated AGEs degradation in vivo, we treated nicotinamide-STZ induced type 2 diabetic mice with daily FIR irradiation of 30 min for 1 or 2 weeks. The oral glucose tolerance test (OGTT) revealed that diabetic mice had higher blood glucose levels during 135 min period compared to normal mice (Supplementary Figure S1) . FIR therapy didn't influence (e) The reducing effect of FIR-induced autophagy on extracellular AGEs in HUVECs. We added 3 ml medium in each 6-cm plate with or without HUVECs, and then incubated it with AGE-BSA (100 μ g/ml) and bafilomycin A1 (BAF, 25 nM) for 48 h as indicated. HUVECs were exposed to FIR at 30 min and 24 h after the AGE-BSA treatment. Each irradiation period is 30 min. Fifteen microliter medium from each sample was applied in western blot analysis with anti-BSA antibody. Data are presented as the mean ± SD (n = 3). *P < 0.05. # No significant difference. the oral glucose tolerance in diabetic mice. Monitoring serum AGEs by ELISA showed that the level of AGEs in diabetic mice was higher than in control mice (35.78 ± 1.46 μ g/ml vs. 21.27 ± 6.17 μ g/ml) (Fig. 5a ). FIR therapy reduced the serum AGEs in both normal and diabetic mice in a dose-dependent manner (Fig. 5a) . In PLZF −/− mice, the basal level of serum AGEs (29.68 ± 3.75 μ g/ml) was higher than in wild-type mice although the fasting serum glucose was similar to that in wild-type mice (99 ± 16 mg/dl vs. 98 ± 11 mg/dl). Diabetes further increased serum AGEs to 38.78 ± 8.38 μ g/ml in PLZF −/− mice. FIR therapy failed to reduce serum AGEs in PLZF −/− mice, but slightly increased serum AGEs instead (Fig. 5a) . IHC results showed that very little CML was detected in vascular endothelium in healthy mice, while obvious endothelial CML was found in diabetic mice (Fig. 5b,c) . The endothelial CML in PLZF −/− mice was also obvious and was further increased by diabetes. FIR therapy for 2 weeks considerably reduced endothelial CML in diabetic mice, but had no influence on PLZF −/− mice (Fig. 5b,c) . Co-immunostaining for CD31 (an endothelial marker) and CML also confirmed CML deposition at vascular endothelium (Supplementary Figure S2) . These results suggest that FIR-induced PLZF activation reduces AGEs in serum and vascular endothelium.
FIR therapy reduces endothelial apoptosis and recovers vascular endothelial function in diabetic mice. FIR-induced AGEs reduction is supposed to reduce endothelial apoptosis and improve vascular function in diabetic mice. We monitored endothelial apoptosis in vascular endothelium by cleaved caspase-3 IHC staining, and found more cleaved caspase-3-positive stained endothelial cells in diabetic mice compared to in control mice (Fig. 6a) . FIR therapy considerably decreased cleaved caspase-3 expression in vascular endothelium in diabetic mice. But the influence of FIR therapy on cleaved caspase-3 was unapparent in diabetic PLZF −/− mice. This result suggests that FIR-induced PLZF activation inhibits diabetes-induced endothelial apoptosis. We also monitored acetylcholine-induced vessel relaxation to test the influence of FIR therapy on endothelial dysfunction in diabetic mice. Acetylcholine-elicited vessel relaxation was severely impaired in diabetic mice (Fig. 6b) . FIR therapy considerably improved the relaxation in response to acetylcholine in diabetic mice, which was blocked by PLZF deficiency (Fig. 6b) . The endothelium-independent NO donor sodium nitroprusside-induced relaxation was not significantly different in all groups (Fig. 6c) . This result suggests that FIR-induced PLZF activation improves diabetes-induced vascular endothelial dysfunction.
FIR therapy reduces endothelial inflammation in diabetic mice. The adhesion of leukocytes to
endothelial cells is an early event in diabetic vascular dysfunction development. Immunochemistry staining revealed that diabetes considerably increased the expression level of CD45, a leukocyte common antigen, in vascular endothelium, suggesting leukocyte adhesion to endothelial cells increased in diabetic mice (Fig. 7a) . Diabetes also considerably increased the expression level of iNOS, typically synthesized in response to inflammatory stimuli, in vascular endothelium (Fig. 7b) . FIR therapy effectively reduced leukocyte-endothelial adhesion
Figure 7. FIR-induced PLZF activation reduces vascular endothelial inflammation in diabetic mice.
Mice were exposed to daily FIR irradiation of 30 min for 2 weeks (F2). The white and black arrows indicate the negative-and positive-stained endothelium of intestinal microvessels respectively. The staining results are also presented as a bar chart form of positive-stained rate of intestinal microvessels (the mean ± SD (n = 6 for wild type, n = 5 for PLZF −/− mice)). DM, diabetic mice. *P < 0.05 vs. the DM wild-type mice without FIR irradiation. and iNOS expression in vascular endothelium of diabetic wild-type mice, but not in diabetic PLZF −/− mice. The serum MCP-1 concentration in diabetic mice was higher than in control mice (Fig. 7c) . FIR therapy considerably reduced serum MCP-1 in diabetic mice. In PLZF −/− mice, the basal level of serum MCP-1 was 16 times higher than in wild-type mice. Diabetes further increased serum MCP-1 in PLZF −/− mice, which was not influenced by FIR therapy. These results suggest that FIR-induced PLZF activation considerably reduces endothelial inflammation in diabetic mice.
Discussion
PLZF is a transcription factor involved in major developmental and biological processes 27 . However, the protective role of PLZF in DM-associated endothelial dysfunction has not been documented. In the present study, we found that PLZF nuclear translocation reduced AGE-induced injury in vascular endothelial cells in vitro and in vivo. In HUVECs, we confirmed that FIR irradiation induced nuclear translocation of PLZF (Fig. 2) . FIR-induced PLZF activation inhibited AGE-induced apoptosis and induced the expression of phosphatidylinositol-3 kinases (PI3Ks) (Figs 1 and 2) . FIR irradiation also induced autophagy in HUVECs, which was blocked by PLZF siRNA transfection (Fig. 3) . Beclin-1 siRNA transfection blocked FIR-induced autophagy and anti-apoptotic effect (Fig. 3) . AGE-BSA has been found to be ingested by microvascular endothelial cells, which could contribute to the pathogenesis of diabetic microangiopathy 28 . FIR-induced PLZF activation promoted AGE-BSA degradation in HUVECs through the involvement of autophagosomes and lysosomes (Fig. 4) . Additionally, the lysosome inhibitor bafilomycin A1 also reduced FIR-induced autophagic signals in HUVECs (Supplementary Figure S3) . These results suggest that FIR-induced PLZF activation induces autophagy to promote AGEs degradation, and then reduces AGE-induced apoptosis in HUVECs. We also found that FIR therapy induced the expression of autophagic markers in vascular endothelium of mice (Fig. 3) . Similar to the in vitro data, FIR therapy reduced serum AGEs in a dose-dependent manner in diabetic mice (Fig. 5a ). FIR therapy also reduced endothelial AGEs, iNOS expression and leukocyte infiltration in the intestinal vascular endothelium in diabetic mice (Figs 5, 6 and 7). Diabetes-induced serum MCP-1 was decreased by FIR therapy (Fig. 7c) . Aorta ring relaxation analysis revealed that FIR therapy improved vascular endothelial function in diabetic mice (Fig. 6b) . However, these protective effects of FIR therapy didn't exist in PLZF −/− mice. Our data suggest that PLZF activation is a potential therapeutic target for DM-associated vascular complications.
Some studies show that autophagy protects HUVECs from AGE-induced injury 25, 26 . However, the detailed protective mechanism of autophagy is still unclear. Our study provides the first evidence that promoting AGEs degradation in vascular endothelial cells plays a role in the protective mechanism of autophagy. The clearance of serum AGEs used to be thought to be associated with macrophages and splenic reticuloendothelial cells 29 . Our results reveal that vascular endothelial cells are also involved in the clearance of serum AGEs. Recently, a diabetic study revealed that AGEs enter proximal tubule epithelial cells via macropinocytosis 30 . Macropinocytosis is a form of endocytosis, and mediates the engulfment of large volumes of extracellular fluid to form macropinosomes at the base of cell membrane ruffles 31 . Macropinocytosis may play an important role in AGEs engulfment and degradation in vascular endothelial cells. However, if AGEs degradation is not efficient, AGEs will accumulate in cells. AGEs accumulation has been proven to be harmful to cells 30 . Our results revealed that autophagy accelerated AGEs degradation in vascular endothelial cells and reduced extracellular AGEs (Fig. 4) . The autophagic-lysosomal pathway is considered the main mechanism involved in removal of misfolded proteins and cell debris 32 . The engulfment of AGEs and autophagy let vascular endothelial cells have potential to decrease extracellular AGEs. In our data, FIR therapy reduced serum AGEs in both healthy and diabetic mice. The levels of serum AGEs in PLZF knockout control mice were similar to those in normal diabetic mice. These data suggest that PLZF-mediated autophagy in vascular endothelial cells plays an important role in the clearance of serum AGEs (Fig. 8) .
Chronic hyperglycemia is a major feature of DM and induces protein glycation reactions leading to AGEs. AGEs are thought to be the major causes of different diabetic complications 7 . AGEs promote both endothelial cell apoptosis and vascular inflammation that contribute to endothelial dysfunction. In our system, FIR-induced AGEs clearance blocks endothelial cell apoptosis in diabetic mice as expected. However, the levels of leukocyte adhesion to endothelium, iNOS in endothelial cells, and serum MCP-1 in FIR-treated diabetic mice were still higher than the basal level of control mice, although they were lower than those in non-treated diabetic mice (Fig. 7) . These results suggest that AGEs are not the only trigger for vascular inflammation in diabetic mice. Recent studies have demonstrated that transient hyperglycemia leads to epigenetic changes in gene promoters resulting in persistent inflammatory responses in endothelial cells 33 . That is to say high glucose also plays a role in triggering vascular inflammation in diabetic mice. However, FIR-induced AGEs clearance still improved diabetes-induced vascular dysfunction and inflammation. AGEs reduction as a whole should be a feasible strategy to keep vascular health in diabetic patients.
Far infrared therapy has been reported to promote new vessel formation in STZ-induced diabetic mice and may be associated with improved quality of life in people with type II diabetes mellitus 34, 35 . The mechanism of these beneficial effects is a puzzle so far. The biological effect of FIR was traditionally considered to be related to a thermal-related mechanism 36 . Although some studies showed that FIR therapy may possess a non-thermal effect, there is no enough direct evidence to support it 37 . Our previous study found that FIR irradiation induced PLZF nuclear translocation in HUVECs, which was independent of a thermal effect 19 . In the present study, we further found that FIR induced autophagy in endothelial cells via PLZF in vitro and in vivo. Some studies shows that autophagy plays a protective role in toxic protein-mediated neurodegeneration, liver disease, and cardiovascular disease 38 . Modulation of autophagy may become a potential treatment for these disease. FIR therapy is the only non-invasive modality to induce autophagy so far, and could also be utilized in the treatment of disease conditions in which autophagy serves as a protective pathway in other tissues. However, more studies are necessary to investigate the existence of FIR-induced autophagy in other cell types.
Scientific RepoRts | 7:40442 | DOI: 10.1038/srep40442 MCP-1 is one of the key chemokines that regulate migration and infiltration of monocytes/macrophages. In PLZF −/− mice, the serum MCP-1 level is about 16 times higher than in wild-type mice, and also 10 times higher than in diabetic wild-type mice (Fig. 7c) . Obviously, this result is impossible to result from AGEs because the levels of serum AGEs in PLZF −/− mice and diabetic wild-type mice are similar (Fig. 5c) . PLZF is shown to be a critical regulator of immune system development and function 27 . The dramatic increase of serum MCP-1 in PLZF −/− mice may result from PLZF gene deficiency, although no report discusses the connection between MCP-1 and PLZF. However, diabetes further increased serum MCP-1 in PLZF −/− mice, which was not influenced by FIR therapy (Fig. 7c) . This result still points out the critical role of PLZF in the inhibitory effect of FIR on diabetes-induced inflammation.
FIR irradiation often possesses a thermal effect because thermal transmission always accompanies FIR emission. The longer irradiation time causes the higher temperature of the target environment. Our previous study revealed that the increase in FIR intensity or irradiation time gradually reduced the biological effect of FIR on PLZF nuclear translocation and its downstream signaling pathways 19 . FIR irradiation at 0.13 mW/cm 2 for 30 min can express the maximum biological effect in cell studies 19 . In the present study, the FIR irradiation conditions were also applied in the animal studies. Furthermore, the treatment condition of AGE-BSA in cell studies is another concern. AGE-BSA is not a strong apoptosis inducer. For studing apoptosis, the AGE-BSA dose often ranges between 100 and 300 μ g/ml, and the treatment time is 24 or 48 h 39, 40 . The level of AGE-BSA-induced apoptosis is dose-and time-dependent. In this study, 250 μ g/ml of AGE-BSA for 48 h was applied to induce obvious apoptosis in HUVECs.
In conclusion, FIR-induced PLZF nuclear translocation induces autophagy through PI3K pathway in vascular endothelial cells. The PLZF-mediated autophagy promotes AGEs degradation in HUVECs and the clearance of serum AGEs in diabetic mice, which further decreases AGE-induced endothelial injury in vitro and in vivo. Through the PLZF-associated pathway, FIR therapy could be a potential therapeutic modality to prevent vascular complications of diabetes.
Methods
Cell culture. HUVECs were purchased from Food Industry Research and Development Institute (Taiwan), and cultured in Medium 200 with low serum growth supplements purchased from Thermo Fisher Scientific (Waltham, MA, USA). They were grown until the monolayer became confluent. AGE-BSA used in cell treatment was purchased from BioVision (Milpitas, CA, USA). All other chemicals of reagent grade were obtained from Sigma-Aldrich (St. Louis, MO, USA).
FIR exposure. Cells were exposed to FIR emitted from a ceramic FIR generator, WS TY101 FIR emitter (WS Far Infrared Medical Technology, Taipei, Taiwan) with the effective energy intensity of 0.13 mW/cm 2 . The control groups were covered with aluminum foil. The whole set was maintained in 37 °C and 5% CO 2 culture condition for 30 min. For mouse experiments, the whole mouse was exposed to FIR at 0.13 mW/cm 2 for 30 min per day. The control mice were exposed to lamps and shaded with aluminum foil from light. 
Apoptosis detection.
STZ-induced diabetic mice. All animal experiments were approved by the Taipei Medical University
Committee of Experimental Animal Care and Use (approval No. LAC-2014-0291), and performed in accordance with relevant guidelines and regulations. Male 8-week-old C57BL/6 J mice were obtained from Lasco Technology (Taiwan). PLZF knock-out (PLZF −/− ) mice arose on the strain C57BL/6 J 41 , and were kindly gifts from Prof. Yung-Hao Ching (Department of Molecular Biology and Human Genetics, Tzu Chi University, Taiwan). Homozygous mutants were crossed to C3HeB/FeJ to generate F1 heterozygotes. The experimental mice (n = 6 per group for wild type, n = 5 per group for PLZF −/− mice) were intraperitoneally injected 150 mg/kg nicotinamide (Sigma), then injected 75 mg/kg streptozotocin (STZ, Sigma, solved in 0.1 M citrate buffer saline) on daily basis for 5 days. After 2 weeks, the second round of nicotinamide-STZ injection was carried out if the blood glucose level remains low (under 300 mg/dl). Dose of STZ in the second round of injection was reduced to 50 mg/kg. Administration of nicotinamide before the streptozotocin injection to the mice protects β -cells from STZ-induced severe cytotoxic damages, leading to chronic DM by producing moderate hyperglycemia 42, 43 . In the present study, the plasma insulin levels in diabetic mice were much higher than those in normal mice, but did not disappear completely (Supplementary Table S1 ). Some type 2 diabetes-induced changes were shown to develop in this model 44 . After FIR irradiation, ears were cut for detecting beclin-1 and LC3 in microvascular endothelium. Large intestines were harvested by laparotomy for detecting microvascular endothelial injury. For histological analysis, we fixed the harvested ears and intestines in 10% formalin and embedded in paraffin.
Aortic ring relaxation assay. Thoracic aorta from mice were cut into rings of 3-4 mm width. Isometric tension was measured in aortic rings as described 45 . In brief, tension changes in the aortic ring were measured by using an isometric transducer (FT03C; Grass, West Warwick, RI, USA) and were recorded on a Grass polygraph. A tension of 1 g was applied and the rings were equilibrated for 60 min. Oxygenated Krebs-Henseleit solution was provided at 15 min intervals. Rings were precontracted with norepinephrine (10 −6 M), and then concentration-response curves to acetylcholine (10 -10 −6 M) were obtained.
